spectral emission lies between 300-60 nm for the blue lamp, with the implication that it is this spectral interval which is required for effective phototherapy is misleading. The spectral emissions of the Sylvania F20T12G (green) and F20T12B (blue) lamps used by these authors are compared here with the spectral emission of another lamp which is also frequently available in hospitals, an ultraviolet lamp used for the phototherapy of psoriasis (figure). A potential source of confusion is that nearly all ultraviolet fluorescent lamps emit a pale blue light not dissimilar from the blue fluorescent lamps used for neonatal phototherapy.
The statement that the spectral emission lies between 300 to 600 nm could equally be made for each of the lamps. Yet if neonates were exposed to the radiation from an ultraviolet fluorescent lamp for the same time that they are normally exposed to 'blue light' the resulting erythema would be severe and possibly fatal.
Although it could be argued from the figure that the spectral emission of the blue light does lie between 300-600 nm, a statement like this is meaningless unless it is qualified by reference to the biological action of the radiation, as all photobiological phenomena, such as erythema, bilirubin dissociation, or photosynthesis show a strong, but different, dependence on the wavelength of the radiation. 
